Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone Acetonide in Bladder Instillations for IC/BPS
NCT03463915Phase 3Completed
- Start
- Jan 2019
- Primary completion
- Oct 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of triamcinolone acetonide in interstitial cystitis (IC) (2 arms). Primary endpoint: O'Leary-Sant Interstitial Cystitis Symptom and Problem Index at 6 weeks. Started Jan 2019; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT03463915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03463915.